Company intelligence / Profile preview

Claritytek

Ownership: Private
Development stage: Phase 2

Overview

Claritytek develops digital therapies—primarily virtual reality-based interventions—for patients with memory issues and cognitive impairments due to Alzheimer's disease, cancer, stroke, and other neurological conditions. Their Moonshot VRCT platform is designed to improve mood and cognitive function through interactive virtual environments tailored for these patient populations. The company emphasizes user-centered design by involving patients in the discovery phase of product development. No traditional clinical trial results are published; products are commercially available.

Therapeutic areas: OncologyNeurology
Modalities: Digital therapyVirtual reality-based therapy
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Claritytek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Claritytek.

Explore the full profile